Accelerated aging — when someone’s biological age is greater than their chronological age — could increase the risk of cancer tumors. That’s according to new research presented this week at the ...

The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?

This study does not only have the possibility of converting Accelerated Approval of resmetirom to full approval [If Accelerated approval for marketing is granted], but also the possibility of ...

A new study by Yale anthropologists has uncovered the first evidence that childbearing may cause accelerated aging in women. The researchers tested 100 healthy postmenopausal women from five rural ...

New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that one's biological age, which can be higher than his or her chronological age – ...

Less than half of the cancer therapies that were granted accelerated approval by the FDA between 2013 and 2017 showed a clinical benefit in a confirmatory trial within the next five years. That is the ...

Researchers looking for clues about why some types of cancer are on the rise in younger adults say they’ve found an interesting lead: a connection to accelerated biological aging. Aging is the major ...

Dec. 3 (UPI) --Annual spending on drugs granted accelerated approval by the Food and Drug Administration increased significantly over the past half decade, a study published Friday by JAMA Health ...

(WTHR) — A large study of brain scans has yielded surprising results for researchers: cannabis use is one of the leading factors of accelerated brain aging. The study, published by the Journal of ...

High-school courses that let students pursue advanced study in mathematics and science should be more in-depth, and should also be made more widely available to poor and minority students, a report ...

The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?